Navigation Links
Scientists discover how deadly fungus protects itself
Date:2/3/2009

February 3, 2009 (Bronx, NY) Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how a deadly microbe evades the human immune system and causes disease.

The study, published in the journal Proceedings of the National Academy of Sciences (PNAS), may help scientists develop new therapies or vaccines against infections caused by Cryptococcus neoformans. These fungal infections occur most commonly in those with compromised immune systems ─ especially AIDS patients and transplant patients who must take lifelong immunosuppressive therapy. The fungus causes an estimated one million deaths each year worldwide, including some 600,000 in sub-Saharan Africa. The lead author of the study was Susana Frases-Carvajal, Ph.D., a postdoctoral fellow in microbiology & immunology at Einstein.

C. neoformans typically enters the body through the lungs and can spread throughout the body, including the brain. The resulting infection, called cryptococcosis, can cause chest pain, dry cough, abdominal swelling, headache, blurred vision, or confusion. The infection can be fatal, especially if not treated with antifungal medications.

"It's a horrendous disease, and even with therapy, you often can't get rid of it," says the paper's senior author, Arturo Casadevall, M.D., Ph.D., professor and chair of microbiology & immunology.

Scientists have known that the capsule surrounding C. neoformans is essential to its ability to cause disease. When the fungus enters a host, the capsule begins to enlarge. "As the capsule grows larger, it reaches a point where immune system scavenger cells, known as macrophages, can't swallow it," says Dr. Casadevall. "But we didn't understand the mechanism responsible for capsule growth."

The protective capsule of C. neoformans is composed of polysaccharides, which are long chains of sugar molecules, or saccharides. Using a technique called dynamic light scattering, Dr. Frases and her colleagues found that the capsule grows by linking more and more saccharides together at the outer edge of the capsule, forming giant molecules pointing in an outward, or axial, direction.

The findings point to potential new targets for drug intervention and reveal a new area of investigation into basic polysaccharide biology. Polysaccharides are poorly understood, partly because of the difficulty of working with them. "Also, scientists have tended to view polysaccharides as boring molecules that simply grow to a specified length," says Dr. Casadevall.

"But this study raises huge questions about polysaccharides," he adds. "For example, how does the organism assemble these molecules, and how does it know how to make molecules that are roughly the same length? We don't know. There appears to be a whole dimension of cellular machinery that we never knew existed."


'/>"/>

Contact: Michael Heller
mheller@aecom.yu.edu
718-430-4186
Albert Einstein College of Medicine
Source:Eurekalert  

Related biology news :

1. UK scientists working to help cut ID theft
2. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
3. Comet probes reveal evidence of origin of life, scientists claim
4. Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA
5. Male elephants get photo IDs from scientists
6. Scientists retrace evolution with first atomic structure of an ancient protein
7. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
8. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
9. Clemson scientists shed light on molecules in living cells
10. Scientists tackle mystery mountain illness
11. T. rex quicker than Becks, say scientists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists discover how deadly fungus protects itself
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
Breaking Biology News(10 mins):
(Date:6/22/2016)... ... June 22, 2016 , ... Quantitative ... business incubator and current participant in the Phase 1 Ventures program, is leveraging ... , Quantitative Radiology Solutions helps physicians make better treatment decisions by quantifying ...
(Date:6/22/2016)... (PRWEB) , ... June 21, 2016 , ... New light-based ... cutting into the tissue — promise to enable both compact, wearable devices for point-of-care ... even deeper under the skin. , Recent work and visionary future directions are detailed ...
(Date:6/22/2016)... SAN DIEGO , June 22, 2016 /PRNewswire/ ... that has developed a testing platform designed specifically ... the formation of their scientific advisory board (SAB). ... of directors, the SAB is chartered to advise ... infectious disease assay platform. Led by Dr. ...
(Date:6/22/2016)... June 22, 2016 On Tuesday, June ... 4,843.76, up 0.14%; the Dow Jones Industrial Average advanced 0.14% ... 2,088.90, up 0.27%. The gains were broad based as five ... has initiated coverage on the following equities: Minerva Neurosciences Inc. ... PTLA ), Trevena Inc. (NASDAQ: TRVN ), ...
Breaking Biology Technology: